Which GERD drug works better? new study compares two popular options
NCT ID NCT07563491
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two medications, esomeprazole and vonoprazan, for treating gastroesophageal reflux disease (GERD). Researchers enrolled 824 adults aged 18 to 65 with GERD and measured how many achieved sufficient symptom relief. The goal was to find which drug works better for managing GERD symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRO ESOPHAGEAL REFLUX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allama Iqbal teaching hospital
Dera Ghazi Khan, Punjab Province, 32200, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three quick endoscopic checks may predict who still has reflux after surgery
- Leg raise test may predict acid reflux risk in obese patients before weight-loss surgery
- New device could make GERD diagnosis quicker and less painful
- Pilates may ease acid reflux without pills
- New registry tracks endoscopic Weight-Loss procedures for safety and success
- Healthy volunteers needed to set new standards for reflux testing